NCT05759793 2025-05-20A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell LeukemiaNanjing IASO Biotechnology Co., Ltd.Phase 1 Recruiting12 enrolled
NCT06045091 2023-09-21To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCLHrain Biotechnology Co., Ltd.Phase EARLY_PHASE1 Recruiting18 enrolled